NEWS FROM:
Location Promotion Switzerland
633 Third Avenue
New York, NY 10017-6706
212 599-5700 Ext. 1063
DNA2.O Establishes EMEA Headquarters in Switzerland
NEW YORK, March 4 – DNA2.O Inc., a California-based gene synthesis and protein engineering company, has established its European, Middle East and African headquarters in Switzerland reports Mario Brossi of the Foreign Investment Agency, Location Promotion Switzerland. Based in Basel, DNA2.0Õs new facility will handle the companyÕs sales and customer service activities throughout the EMEA region, Mr. Brossi said.
In commenting on the location Dr. Claes Gustafsson, Vice President Sales and Marketing, said ÒSwitzerland was a top candidate as a site for our EMEA operations from the start. It quickly became clear that Basel's excellent location on the German and French borders and its role as a European biotech center made it a perfect fit for our activities. It puts us close to many of our European customers, and the adjoining Euro Airport along with excellent rail and highway connections provide access throughout Europe, the UK and beyond.Ó
Mr. Brossi noted that ÒSwitzerland's well-established and world-renowned life sciences companies, combined with the strength of its universities and technical institutes, have helped to build an innovative and dynamic biotechnology industry. With some 137 biotech companies and 81 biotech suppliers,Ó he said, Òthe country boasts the worldÕs highest per capita biotech density, and in 2006 generated a turnover of some 6 billion Swiss Francs ($5.52 billion) generated by a highly skilled workforce of over 14,000 persons.Ó
Companies in the industry range from leading multinationals to innovative university start-ups, and the industry is well diversified, with firms conducting R&D activities in all areas of the life sciences.
-0-
Contacts:
DNA2.O: Dr. Claes Gustafsson +650 853 8347
Location Promotion Switzerland: John Williamson + 908 730-9622